Key result
Increased aortic stiffness correlates with the presence of micro- and macrovascular chronic diabetic complications in patients with type 2 diabetes.
Why the study?
Does aortic stiffness predict micro- and macrovascular complications in patients with type 2 diabetes?
Does aortic stiffness predict micro- and macrovascular complications in patients with type 2 diabetes?
Aortic stiffness serves as a potential surrogate marker for micro- and macrovascular complications in patients with type 2 diabetes.
May support aortic stiffness as surrogate marker in T2D; leaves open prospective validation and causal inference.
Increased aortic stiffness has been recognized as a predictor of adverse cardiovascular outcomes in some clinical conditions, such as in patients with arterial hypertension and end-stage renal disease, in population-based samples and, more recently, in type 2 diabetic patients. Patients with type 2 diabetes have higher aortic stiffness than non-diabetic individuals, and increased aortic stiffness has been correlated to the presence of micro- and macrovascular chronic diabetic complications. We aimed to review the current knowledge on the relationships between aortic stiffness and diabetic complications, their possible underlying physiopathological mechanisms, and their potential applications to clinical type 2 diabetes management.
No takes yet. Share an insight, caveat, or question.
Cardoso et al. (2016) conducted a review in Type 2 Diabetes. Aortic stiffness was evaluated. Increased aortic stiffness correlates with the presence of micro- and macrovascular chronic diabetic complications in patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: